Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia

Clinical Cardiology

Volumn 23, Issue 9, 2000, Pages 682-688

  Recto, Cesar S ^a   Acosta, Stella ^b   Dobs, Adrian ^c  

^a PHILIPPINE HEART CENTER   (Philippines)

^b HOSPITAL DE SAN JOSÉ   (Colombia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 Hydroxy 3 methylglutaryl coenzyme A reductase inhibitors; Atorvastatin; Hypercholesterolemia; Low density lipoprotein cholesterol; Simvastatin; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; ATORVASTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGINA PECTORIS; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE CRAMP; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033804840     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230910     Document Type: Article

References (21)

1. Cholesterol reduction in cardiovascular disease: Clinical benefits and possible mechanisms
2. Cholesterol and mortality 30 years of follow-up from the Framingham study
3. Serum cholesterol and coronary heart disease in populations with low cholesterol concentration
4. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel II)
5. Long-term experience with HMG CoA reductase inhibitors in the therapy of hypercholesterolemia
6. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: Scandinavian Simvastatin Survival Study (4S)
7. Extended follow-up of patients in the Scandinavian Simvastatin Survival Study (4S) shows increased survival benefit of simvastatin therapy
8. Effect of simvastatin on coronary artheroma: The Multicentre Anti-Atheroma Study (MAAS)
9. Reduction of LDL-cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor
10. Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia
11. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge
12. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II)
13. Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease
14. The triglyceride issue: A view from Framingham
15. Plasma triglyceride and coronary heart disease
16. Comparison of statins in hypertriglyceridemia
17. Three-year follow-up of the Oxford Cholesterol Study: Assessment of the efficacy and safety of simvastatin in preparation for a large mortality study
18. 2-cholesterol under prolonged simvastatin treatment
19. Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia